Research News

---

Topic: Diagnosis (view all topics)

Tags for topic Diagnosis:

• 1cm-1.9cm
• Ductal Carcinoma In Situ
• Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ)
• Early-stage: Stage IA
• Early-stage: Stage IB
• Early-stage: Stage IIA
• Early-stage: Stage IIB
• Early-stage: Stage IIIA
• Estrogen Receptor Negative Cancer
• Estrogen Receptor Positive Cancer
• HER2/neu Negative Cancer
• HER2/neu Positive Cancer
• HER2 Overexpressing
• Invasive or Infiltrating Ductal Carcinoma
• Invasive or Infiltrating Lobular Carcinoma
• Less than 1cm
• Locally Advanced-stage: Stage IIIB
• Locally Advanced-stage: Stage IIIC
• Luminal A
• Luminal B
• Metastatic
• Metastatic/Advanced-stage: Stage IV
• Non-Metastatic
• Progesterone Receptor Negative Cancer
• Progesterone Receptor Positive Cancer
• Regional
• Triple Negative

View articles by month and year

• Quality Personal Relationships Boost Survival in Women Diagnosed with Early-Stage Breast Cancer

  Published on November 17, 2012 at 12:00 am

  • Tags: Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, and Support Groups

  A study suggests that the quality of a woman’s social networks seems to be just as important as the size of the social networks in predicting breast cancer survival.

• Mammostrat Test Helps Estimate Recurrence Risk and Make Treatment Decisions

  Published on October 16, 2012 at 12:00 am

  • Tags: Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Estrogen Receptor Positive Cancer, and Progesterone Receptor Positive Cancer

  A study shows that the Mammostrat test can offer more information on the risk of early-stage, hormone-receptor-positive breast cancer coming back in postmenopausal women and help make treatment decisions.

• Study Analyzes Breast Cancer Genetics, Finds Four Classes of Disease

  Published on September 25, 2012 at 12:00 am

  • Tags: Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Negative Cancer, HER2/neu Positive Cancer, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  Researchers have done the most thorough analysis of breast cancer genetics to date and found that there are four genetically distinct classes of the disease.

• FDA Advisory Panel Approves MarginProbe System

  Published on June 26, 2012 at 12:00 am

  • Tags: Ductal Carcinoma In Situ, Invasive or Infiltrating Ductal Carcinoma, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Lumpectomy, Non-Metastatic, and Invasive or Infiltrating Lobular Carcinoma

  An FDA expert panel voted to approve the MarginProbe system - a device that helps surgeons decide if all the cancer tissue has been removed during lumpectomy.

• Circulating Tumor Cells Linked to Worse Prognosis in Early-Stage Disease

  Published on June 19, 2012 at 12:00 am

  • Tags: Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Non-Metastatic, and Blood Marker Tests

  A study has found that circulating tumor cells in the bloodstream are linked to worse prognosis in people diagnosed with early-stage breast cancer.

• Women Older Than 65 Have Worse Outcomes After Breast Cancer Diagnosis

  Published on February 7, 2012 at 12:00 am

  • Tags: Progesterone Receptor Positive Cancer, Estrogen Receptor Positive Cancer, Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  A large study has found that women older than 65 diagnosed with early-stage, hormone-receptor-positive breast cancer had worse outcomes than younger women with similar diagnoses.

• Breast Cancer Cells in Sentinel Lymph Node Don’t Affect Survival

  Published on July 26, 2011 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  Research strongly suggests that occult metastases in the sentinel lymph node of women diagnosed with early-stage breast cancer don't affect survival.

• High C-Reactive Protein Levels May Influence Prognosis

  Published on June 3, 2011 at 12:00 am

  • Tags: Invasive or Infiltrating Ductal Carcinoma, Invasive or Infiltrating Lobular Carcinoma, Non-Metastatic, Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, and Locally Advanced-stage: Stage IIIC

  Research suggests that C-reactive protein levels may be linked to prognosis after a breast cancer diagnosis.

• Single Cancer Cells in Sentinel Node Don’t Affect Prognosis

  Published on January 19, 2011 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  A large study suggests that women diagnosed with early-stage breast cancer who have occult metastases in a clinically negative sentinel node do almost as well as women without occult metastases.

• Circulating Tumor Cells Linked to Worse Prognosis

  Published on December 15, 2010 at 12:00 am

  • Tags: Metastatic, Non-Metastatic, Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, and Blood Marker Tests

  New studies suggest that even one circulating tumor cell in a blood sample from a woman diagnosed with breast cancer is linked to a worse prognosis.